l carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to A systematic review of TMAO,
A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




